UroLift

What is UroLift?

Most men living with mild symptoms of enlarged prostate (BPH) take oral medication after diagnosis. However, these medications often do not provide adequate relief and can cause dizziness, fatigue and sexual dysfunction. Taking this medication does not have to become a lifelong burden for these patients with therapeutic alternatives such as the UroLift System.

Treatment with the UroLift® System provides rapid relief and recovery for men living with the symptoms of an enlarged prostate. Through the use of implants placed in the prostatic lobes, this therapy causes an unblocking of the lower urinary tract, pursuing two objectives: on the one hand, to relieve the symptomatology and, on the other hand, to slow down the progression of the disease and the appearance of associated complications.

The UroLift System has demonstrated a significant improvement in patients' quality of life compared to oral medication, being one of the safe and effective surgical procedures for BPH that does not cause erectile or ejaculatory dysfunction.

This treatment uses the pressure exerted by the implants placed in the transitional zone of the prostate to reduce the pressure it exerts on the urethra, favoring a wider channel for the evacuation of urine from the bladder. The treatment delivery device is introduced through the urethra and the implants are placed on the prostatic surface, with one end at the urethral level and the other at the level of the prostatic capsule. In this way, the obstructive prostatic lobe is compressed as if it were a staple. These implants are inserted in the prostatic tissue, in areas previously planned in an individualized manner.

The UroLift system comes to urology as an alternative treatment for patients with mild symptoms or initial stages who are candidates for medical treatment. In this sense, it becomes a potential alternative to medication, either by the patient's own decision, who does not want a treatment prescribed for years, or because of the side effects or drug interactions with their usual treatment that these may cause.

Therefore, UroLift is not a valid treatment for all patients with BPH but only for patients strictly selected on the basis of a series of personal, clinical and anatomical parameters (in all cases prostate size must be taken into account, being indicated for prostates no larger than 80cc). It is important, therefore, a complete evaluation by the urologist specializing in this therapy in order to decide whether it is the one that will provide the best results for the patient or whether, on the contrary, he should opt for other therapeutic alternatives.